Search This Blog

Sunday, April 6, 2014

Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014 (NYSE:LLY)

INDIANAPOLIS, April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies - including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 - that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 - 9.



Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014 (NYSE:LLY)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)